Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer

Clinical Lung Cancer

Volumn 16, Issue 6, 2015, Pages e165-e171

  He, Xiaobo ^a,b   Zhou, Ting ^a,b   Yang, Yunpeng ^a,b   Hong, Shaodong ^a,b   Zhan, Jianhua ^a,b   Hu, Zhihuang ^a,b   Fang, Wenfeng ^a,b   Qin, Tao ^a,b   Ma, Yuxiang ^a,b   Zhao, Yuanyuan ^a,b   Cheng, Zhibin ^c   Huang, Yan ^a,b   Zhao, Hongyun ^a,b   Yang, Guangwei ^c   Zhang, Li ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Department of Colorectal Surgery   (China)

^c THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biomarker; Carcinoma; Inexpensive cost; Prognosis; Widely available

Indexed keywords

ETOPOSIDE; IRINOTECAN; LACTATE DEHYDROGENASE;

ADULT; ADVANCED LUNG CANCER INFLAMMATION INDEX; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGNOSTIC ASSESSMENT; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SERUM ALBUMIN NEUTROPHIL LYMPHOCYTE RATIO; SMALL CELL LUNG CANCER; SURVIVAL RATE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; CANCER STAGING; CARCINOMA, SMALL CELL; FOLLOW UP; INFLAMMATION; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84944357652     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2015.03.005     Document Type: Article

References (38)

1. R. Siegel, J. Ma, Z. Zou, and et al. Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. S.S. Devesa, F. Bray, A.P. Vizcaino, and et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising Int J Cancer 117 2005 294 299
3. A. Qin, Y. Qian, W. Cao, and et al. Analysis and comparison of the prognosis of combined and pure small cell lung cancer Zhongguo Kang Ai Xie Hui 41 2014 720 723
4. X. Yao, H. Zhnag, Q. Pu, and et al. Clinical epidemiology and histological characteristics of patients with lung cancer in West China Hospital of Sichuan University [in Chinese] Sichuan Da Xue Xue Bao Yi Xue Ban 45 2014 309 315
5. J. Kong, F. Xu, M. He, and et al. The incidence of lung cancer by histological type: a population-based study in Tianjin, China during 1981-2005 Respirology 19 2014 1222 1228
6. M. Zelen Keynote address on biostatistics and data retrieval Cancer Chemother Rep 3 4 1973 31 42
7. F.A. Shepherd, J. Crowley, P. Van Houtte, and et al. The IASLC Lung Cancer Staging Project: proposals regarding the clinical staging of small-cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 77
8. T. Cerny, V. Blair, H. Anderson, and et al. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients Int J Cancer 39 1987 146 149
9. K.S. Albain, J.J. Crowley, M. LeBlanc, and et al. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base J Clin Oncol 8 1990 1563 1574
10. J.S. Gronowitz, R. Bergstrom, E. Nou, and et al. Clinical and serologic markers of stage and prognosis in small-cell lung cancer. A multivariate analysis Cancer 66 1990 722 732
11. U. Sagman, E. Maki, W.K. Evans, and et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system J Clin Oncol 9 1991 1639 1649
12. R.M. Bremnes, S. Sundstrom, U. Aasebo, and et al. The value of prognostic factors in small-cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up Lung Cancer 39 2003 303 313
13. S.P. Hussain, and C.C. Harris Inflammation and cancer: an ancient link with novel potentials Int J Cancer 121 2007 2373 2380
14. M.J. Batista, S.B. Peres, M.E. McDonald, and et al. Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors Cytokine 57 2012 9 16
15. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
16. A. Mantovani, P. Allavena, A. Sica, and et al. Cancer-related inflammation Nature 454 2008 436 444
17. T.L. Whiteside The tumor microenvironment and its role in promoting tumor growth Oncogene 27 2008 5904 5912
18. S.R. Walsh, E.J. Cook, F. Goulder, and et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181 184
19. T. Yamanaka, S. Matsumoto, S. Teramukai, and et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology 73 2007 215 220
20. K.M. Sarraf, E. Belcher, E. Raevsky, and et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small-cell lung cancer J Thorac Cardiovasc Surg 137 2009 425 428
21. V. Pasceri, and G. Cammarota C-reactive protein and risk of colon cancer JAMA 291 2004 2818 2819
22. K. Aleksandrova, H. Boeing, U. Nothlings, and et al. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer Hepatology 60 2014 858 871
23. C. Chen, P. Sun, Q.S. Dai, and et al. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma PLoS One 9 2014 e112581
24. S.H. Jafri, R. Shi, and G. Mills Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small-cell lung cancer (NSCLC): a retrospective review BMC Cancer 13 2013 158
25. J.F. Feng, Y. Huang, and Q.X. Chen A new inflammation index is useful for patients with esophageal squamous cell carcinoma Onco Targets Ther 7 2014 1811 1815
26. J. Budczies, F. Klauschen, B.V. Sinn, and et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization PLoS One 7 2012 e51862
27. S. Demaria, E. Pikarsky, M. Karin, and et al. Cancer and inflammation: promise for biologic therapy J Immunother 33 2010 335 351
28. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
29. S. Hong, Y.A. Kang, B.C. Cho, and et al. Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer Yonsei Med J 53 2012 111 117
30. M.H. Kang, S.I. Go, H.N. Song, and et al. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer Br J Cancer 111 2014 452 460
31. T.P. Erlinger, E.A. Platz, N. Rifai, and et al. C-reactive protein and the risk of incident colorectal cancer JAMA 291 2004 585 590
32. C. Siemes, L.E. Visser, J.W. Coebergh, and et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study J Clin Oncol 24 2006 5216 5222
33. D.C. McMillan Systemic inflammation, nutritional status and survival in patients with cancer Curr Opin Clin Nutr Metab Care 12 2009 223 226
34. H.J. Moshage, J.A. Janssen, J.H. Franssen, and et al. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation J Clin Invest 79 1987 1635 1641
35. D.C. McMillan, W.S. Watson, P. O'Gorman, and et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss Nutr Cancer 39 2001 210 213
36. E. Espinosa, J. Feliu, P. Zamora, and et al. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer Lung Cancer 12 1995 67 76
37. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578
38. J.E. Olson, P. Yang, K. Schmitz, and et al. Differential association of body mass index and fat distribution with three major histologic types of lung cancer: evidence from a cohort of older women Am J Epidemiol 156 2002 606 615